Til hovedinnhold
Norli Bokhandel

Treatment-Resistant Schizophrenia - Evidence-based Pharmacotherapy, Cognitive Behavioral Psychotherapy and Rehabilitation

2024, Heftet, Engelsk

869,-

Bestillingsvare – sendes normalt innen 10-14 virkedager
  • Gratis frakt på ordre fra 299,-
  • Bytt i 200 butikker
  • Ikke tilgjengelig for hent i butikk
Treatment-resistant schizophrenia is one of the most challenging mental health disorders and is associated with a high risk of relapse, repeated hospitalizations, suicidal behavior and poor quality of life. This book focuses on treatment-resistant schizophrenia, its clinical features, and evidence-based treatments: pharmacotherapy, cognitive-behavioral psychotherapy, and rehabilitation. A novel therapy targeting long-term recovery for treatment-resistant schizophrenia is discussed. The cognitive, metacognitive, and recovery perspectives represent the main elements. Each chapter begins with an abstract, followed by learning objectives, introduction, main text, discussion, conclusion, review questions, and bibliography. This structure, including learning objectives and review questions, reinforces the reader's learning process. It can also help improve the teaching process in seminars and courses.   

Produktegenskaper

  • Forfatter

  • Bidragsyter

    Georgila, Polyxeni (Forfatter)
  • Forlag/utgiver

    Springer International Publishing AG
  • Format

    Heftet
  • Språk

    Engelsk
  • Utgivelsesår

    2024
  • Antall sider

    92
  • Varenummer

    9783031646225

Kundeanmeldelser

Frakt og levering